391 related articles for article (PubMed ID: 16026113)
1. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
2. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
4. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
6. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Ziegler D; Gries FA
Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
[TBL] [Abstract][Full Text] [Related]
7. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
[TBL] [Abstract][Full Text] [Related]
9. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
10. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.
Ziegler D; Low PA; Litchy WJ; Boulton AJ; Vinik AI; Freeman R; Samigullin R; Tritschler H; Munzel U; Maus J; Schütte K; Dyck PJ
Diabetes Care; 2011 Sep; 34(9):2054-60. PubMed ID: 21775755
[TBL] [Abstract][Full Text] [Related]
13. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
[TBL] [Abstract][Full Text] [Related]
14. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie.
Ziegler D; Schatz H; Conrad F; Gries FA; Ulrich H; Reichel G
Diabetes Care; 1997 Mar; 20(3):369-73. PubMed ID: 9051389
[TBL] [Abstract][Full Text] [Related]
15. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
16. Thioctic acid-induced acute cholestatic hepatitis.
Ridruejo E; Castiglioni T; Silva MO
Ann Pharmacother; 2011 Jul; 45(7-8):e43. PubMed ID: 21672886
[TBL] [Abstract][Full Text] [Related]
17. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
[TBL] [Abstract][Full Text] [Related]
18. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
Vereşiu IA
Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
[TBL] [Abstract][Full Text] [Related]
19. α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.
Papanas N; Maltezos E
Angiology; 2012 Feb; 63(2):81-3. PubMed ID: 22253286
[TBL] [Abstract][Full Text] [Related]
20. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
Strokov IA; Phokina AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
